If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Supplementary Prospectus

29 Mar 2023 14:19

RNS Number : 6537U
Maven Income and Growth VCT 3 PLC
29 March 2023
 

Joint Announcement

Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC, and Maven Income and Growth VCT 5 PLC (the "Companies")

Issue of Supplementary Prospectus

The Boards of the Companies today announce that they have published a supplementary prospectus (the "Supplementary Prospectus") relating to the offers for subscription issued by the Companies, details of which were set out in their prospectus (comprising a securities note, registration document and summary) issued on 7 October 2022.

The publication of the Supplementary Prospectus is a regulatory requirement under the Prospectus Regulation Rules and Section 87G of The Financial Services and Market Act 2000 following the publication by each of Maven Income and Growth VCT 3 PLC (on 14 March 2023) and Maven Income and Growth VCT 5 PLC (on 23 March 2023) of their respective Annual Report and Financial Statements for the year ended 30 November 2022.

 

The Supplementary Prospectus has been approved by the Financial Conduct Authority, and a copy will shortly be available for inspection at the National Storage Mechanism, which is located at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. Copies of the Supplementary Prospectus are available free of charge from the office of the investment manager of the Companies, Maven Capital Partners UK LLP, at Kintyre House, 205 West George Street, Glasgow G2 2LW and from the website of Maven Capital Partners UK LLP at: www.mavencp.com/vctoffer.

Enquiries

For further information, please contact:

Maven Capital Partners UK LLP

Tel: 0141 306 7400

E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLP

Secretary

29 March 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDISEFFDUEDSEFD
Date   Source Headline
3rd May 20132:50 pmRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSDirector/PDMR Shareholding
30th Apr 20134:55 pmRNSIssue of Equity
30th Apr 20134:47 pmRNSNet Asset Value(s)
30th Apr 20134:44 pmRNSAnnual Financial Report
8th Apr 201311:29 amRNSIssue of Equity
5th Apr 20134:21 pmRNSNAV and updated subscription price
3rd Apr 20131:54 pmRNSMerger Results
26th Mar 20132:04 pmRNSRestults of General Meeting and Class Meetings
4th Mar 20136:08 pmRNSFurther re merger offer
4th Mar 20134:49 pmRNSFurther re merger and offer
4th Mar 20134:47 pmRNSFurther re merger and Offer
4th Mar 20137:00 amRNSDoc re posting of proposed merger documents
4th Mar 20137:00 amRNSAnnouncement re: posting of merger documents
1st Mar 201311:49 amRNSDividend Declaration and unaudited NAV
1st Mar 20137:00 amRNSDividend Declaration
13th Feb 201312:11 pmRNSMerger Update
9th Nov 20125:01 pmRNSInterim Management Statement
31st Oct 20125:03 pmRNSHalf Yearly Report
31st Oct 20124:25 pmRNSDoc re. Joint Announcement of Potential Merger
31st Oct 20124:25 pmRNSDoc re. Joint Announcement of Potential Merger
28th Aug 20125:24 pmRNSHalf Yearly Report
12th Jul 20125:01 pmRNSAnnual Information Update
17th May 20121:02 pmRNSResult of AGM
17th May 20129:31 amRNSInterim Management Statement
3rd May 20125:36 pmRNSTransaction in Own Shares
2nd May 20124:12 pmRNSDirector/PDMR Shareholding
2nd May 20123:59 pmRNSDirector/PDMR Shareholding
2nd May 20123:30 pmRNSTransaction in Own Shares
26th Apr 20122:24 pmRNSTransaction in Own Shares
20th Apr 20121:11 pmRNSIssue of Equity
18th Apr 201212:26 pmRNSAnnual Financial Report - Replacement
17th Apr 20124:40 pmRNSAnnual Financial Report
10th Apr 20129:59 amRNSIssue of Equity
8th Mar 20124:02 pmRNSDirector/PDMR Shareholding
2nd Mar 20129:39 amRNSIssue of Equity
7th Dec 20114:20 pmRNSIssue of Equity
22nd Nov 20114:45 pmRNSTransaction in Own Shares
17th Nov 20114:55 pmRNSTransaction in Own Shares
16th Nov 20113:09 pmRNSInterim Management Statement
29th Sep 20115:04 pmRNSTransaction in Own Shares
15th Aug 20113:34 pmRNSHalf Yearly Report
1st Jul 20117:00 amRNSTransaction in Own Shares
29th Jun 20112:44 pmRNSTransaction in Own Shares
29th Jun 20112:43 pmRNSTransaction in Own Shares
14th Jun 201110:51 amRNSStatement re cancellation of share premium
24th May 20113:27 pmRNSAnnual Information Update
20th May 20114:16 pmRNSInterim Management Statement
12th May 201111:08 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.